The observed sevelamer-mediated attenuation of hepatic fibrosis coincided with a decline in the hepatic expression levels of profibrotic genes including Col1a1, Acta2, and Tgfb1 (Figure 3F). This evidence concerns the gene ACTA2 and Hepatic fibrosis.